PrEPared to choose: the protocol for an implementation study of the delivery of cabotegravir long-acting injectable pre-exposure prophylaxis (PrEP) as an HIV prevention product option within a real world PrEP choice context in cape town

By afschroeder • September 25, 2025

Pike C, Rousseau E, Macdonald P, Mapukata P, Lebelo K, Joseph-Davey D, Little F, Bekker LG. PrEPared to choose: the protocol for an implementation study of the delivery of cabotegravir long-acting injectable pre-exposure prophylaxis (PrEP) as an HIV prevention product option within a real world PrEP choice context in cape town. BMC Public Health. 2025 Sep 24;25(1):3109. doi: 10.1186/s12889-025-24370-z. PMID: 40993613.

Tags: Adolescents and young people, HIV prevention, Infectious Diseases, Injectable PrEP, PrEP choice, Publications, south africa

West Nile Morbidity and Mortality in a Mid-Atlantic Health Care System, 2013-2024

Judson SD, Auwaerter P, Dowdy D. West Nile Morbidity and Mortality in a Mid-Atlantic Health Care System, 2013-2024. Am J Trop Med Hyg. 2026 Apr[...]

Church-based problem-solving therapy for adolescent girls and young women with a history of gender-based violence in Zambia: study protocol for a hybrid type 1 randomized controlled trial

Ahmed CV, Thornicroft M, Chileshe K, Ntebeka BM, Dovel K, Bogart LM, Chávez NR, Bwalya FT, Brooks MJ, Swendeman D. Church-based problem-solving therapy for adolescent[...]

Integrin ß4 is a receptor for emerging fungal pathogens from the genera Lomentospora and Scedosporium

Kavaliauskas P, Risteen R, Alkhazraji S, Shirtliff B, Walsh TJ, Ibrahim AS, Bruno VM. Integrin ß4 is a receptor for emerging fungal pathogens from the[...]